Hannah Pflaumer
Overview
Explore the profile of Hannah Pflaumer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brunner A, Morero N, Zhang W, Hossain M, Lampe M, Pflaumer H, et al.
J Cell Biol
. 2025 Jan;
224(3).
PMID: 39786339
How cells establish the interphase genome organization after mitosis is incompletely understood. Using quantitative and super-resolution microscopy, we show that the transition from a Condensin to a Cohesin-based genome organization...
2.
Brunner A, Morero N, Zhang W, Hossain M, Lampe M, Pflaumer H, et al.
bioRxiv
. 2024 Jun;
PMID: 38854067
How cells establish the interphase genome organization after mitosis is incompletely understood. Using quantitative and super-resolution microscopy, we show that the transition from a Condensin to a Cohesin-based genome organization...
3.
Wyllie S, Thomas M, Patterson S, Crouch S, De Rycker M, Lowe R, et al.
Nature
. 2023 Jul;
619(7970):E48.
PMID: 37402863
No abstract available.
4.
Rauscher B, Mueller W, Clauder-Munster S, Jakob P, Islam M, Sun H, et al.
J Biochem
. 2021 Dec;
171(2):187-199.
PMID: 34878535
N-Glycanase 1 (NGLY1) deficiency is a rare and complex genetic disorder. Although recent studies have shed light on the molecular underpinnings of NGLY1 deficiency, a systematic characterization of gene and...
5.
Wyllie S, Thomas M, Patterson S, Crouch S, De Rycker M, Lowe R, et al.
Nature
. 2018 Jul;
560(7717):192-197.
PMID: 30046105
Visceral leishmaniasis causes considerable mortality and morbidity in many parts of the world. There is an urgent need for the development of new, effective treatments for this disease. Here we...
6.
Wilson C, Gessner R, Moosa A, Seldon R, Warner D, Mizrahi V, et al.
J Med Chem
. 2017 Nov;
60(24):10118-10134.
PMID: 29148755
A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in biology...
7.
Park Y, Pacitto A, Bayliss T, Cleghorn L, Wang Z, Hartman T, et al.
ACS Infect Dis
. 2016 Oct;
3(1):18-33.
PMID: 27704782
A potent, noncytotoxic indazole sulfonamide was identified by high-throughput screening of >100,000 synthetic compounds for activity against Mycobacterium tuberculosis (Mtb). This noncytotoxic compound did not directly inhibit cell wall biogenesis...